The Morning Ledger: Tech Valuations Raise Eyebrows

News Editor

Biotechnology and Internet company share prices took a dive on Thursday, dragging down the Nasdaq to its worst daily decline since 2011, the WSJ’s E.S. Browning reports. Investor worries that those sectors’ shares are suffering from bloated valuations were behind the move, but the malaise hasn’t been contagious – the blue-chip-focused Dow Jones Industrial Average has suffered far less.